Executive Summary The United States National Security Agency (NSA), the U.S. Federal Bureau of Investigation (FBI), the U.S. Cybersecurity and…
Read More →
Case Name: Astellas Pharma Inc. v. Sandoz Inc., Civ. No. 20-1589, 2023 WL 3934386 (D. Del. June 9, 2023) (Bataillon,…
Read More →
There is a lot of chatter out there around the uses of artificial intelligence (AI) for cybersecurity. For example, Applied…
Read More →
The looming government shutdown will likely slow the pace of work at the FDA. The federal government will shut down…
Read More →
Not only is the People’s Republic of China (PRC) a threat with its use of TikTok, but it also supports…
Read More →
Artificial Intelligence (AI) is not just a technological innovation; it’s a transformative force that has permeated multiple sectors, from healthcare…
Read More →
Are you a diabetes patient who took Ozempic? Did you take Wegovy in hopes of losing weight? Have you suffered…
Read More →
Recently, U.S. lawmakers put Amazon and its top executives on the hot seat, raising questions about the retail giant’s commitment…
Read More →
Case Name: In re Sugammadex, No. 20-CV-2576 (CCC/LDW), 2023 WL 3966146 (D.N.J. June 13, 2023) (Cecchi, J.) Drug Product and…
Read More →
The U.S. Department of Homeland Security (DHS) announced new policies on September 14, 2023, regarding its use and acquisition of…
Read More →